Type here to filter the list

Saturday, Oct 17th
8:15 AM - 9:15 AM EST
AM26-SA-04-L - How Low Can You Go? Defining Safe Lower-weight Boundaries for Pediatric Apheresis
Room: GWCC B401-402
Program Chair: John Manis, M.D. – Boston Children’s Hospital
Speaker: Reuben P. Jacob, MD – Children's Healthcare of Atlanta+Emory University
Speaker: Kyle Annen, D.O. – Children's Hospital of Colorado
Biotherapies, Cellular Therapies, and Immunotherapies
Saturday, Oct 17th
8:15 AM - 9:15 AM EST
AM26-SU-12-L - Chimeric Antigen Receptor T Cell Manufacturing: An Evolving out of Body Experience
Room: GWCC B404
Program Chair: Vijay Bhoj, MD, PhD – University of Pennsylvania
Speaker: Saba Ghassemi, PhD – Perelman School of Medicine, University of Pennsylvania
Speaker: Jose Cancelas, MD, PhD (he/him/his) – Dana-Farber Cancer Institute
Biotherapies, Cellular Therapies, and Immunotherapies
Saturday, Oct 17th
9:30 AM - 10:30 AM EST
AM26-SA-15-L - Navigating the Intersection: Collaborative Management of Complex Cases in Transfusion Medicine and Biotherapies
Room: GWCC B401-402
Program Chair: Chloe Homich, MLS(ASCP)SBB, CQA(ASQ) (she/her/hers) – New York Blood Center Enterprises
Speaker: Thomas Z. Thompson, MD, FCAP, CABP (he/him/his) – Mayo Clinic
Speaker: Vasiliki E. Kalodimou, Professor/Dr MSc, PhD, CABP (H) (she/her/hers) – IASO, EUC Frankfurt Branch
Biotherapies, Cellular Therapies, and Immunotherapies
Saturday, Oct 17th
10:45 AM - 12:00 PM EST
AM26-SA-24-L - Sterility Testing for Section 361 HCT/Ps: Clarifying CGTP Expectations and the Role of CLIA Laboratories to Ensure Patient Safety and Compliance
Room: GWCC B405
Program Chair: Bill Ward, MT(ASCP)DLM, LSSGB, CABP – Vitalant
Speaker: Ronit Slotky, PhD, MSc, CABP (she/her/hers) – Hackensack University Medical Center
Speaker: Yvette C. Tanhehco, PhD, MD, MS, CABP(AABB) (she/her/hers) – Columbia University Irving Medical Center
Speaker: Dr. Anna Lau, PhD, D(ABMM) (she/her/hers) – National Institutes of Health
Biotherapies, Cellular Therapies, and Immunotherapies
Saturday, Oct 17th
1:30 PM - 2:30 PM EST
AM26-SA-28-L - A Roadmap for Immune Effector Cell Therapy in the Community Oncology Setting
Room: GWCC B308-309
Program Chair: Scott A. Koepsell, MD, PhD – University of Nebraska Medical Center
Speaker: Brian White, MLS (ASCP) BB – Nebraska Medicine
Speaker: Jensyn Cone Sullivan, MD, CABP (she/her/hers) – The University of Michigan
Biotherapies, Cellular Therapies, and Immunotherapies
Saturday, Oct 17th
1:30 PM - 2:30 PM EST
AM26-SA-30-L - Ask the Standards
Room: GWCC B313-314
Program Chair: Christopher Bocquet, n/a (he/him/his) – AABB
Speaker: Audra L. Taylor, MS, SBB(ASCP) – South Texas Blood & Tissue
Speaker: Yvette C. Tanhehco, PhD, MD, MS, CABP(AABB) (she/her/hers) – Columbia University Irving Medical Center
Biotherapies, Cellular Therapies, and Immunotherapies
Sunday, Oct 18th
4:30 PM - 5:45 PM EST
AM26-SU-28-L - Solve It Scenarios in Cellular Therapy
Room: GWCC B302-303
Program Chair: Vasiliki E. Kalodimou, Professor/Dr MSc, PhD, CABP (H) (she/her/hers) – IASO, EUC Frankfurt Branch
Speaker: Ronit Slotky, PhD, MSc, CABP (she/her/hers) – Hackensack University Medical Center
Biotherapies, Cellular Therapies, and Immunotherapies
Sunday, Oct 18th
9:45 AM - 11:00 AM EST
AM26-SU-05-L - Cell Therapy Millionaire: A Game Show Experience Across the Vein-to-vein Continuum
Room: GWCC B312-313A
Moderator: Laura Staller, MHA, MLS(ASCP) (she/her/hers) – NMDP
Speaker: Huy P. Pham, MD, MPH – NMDP
Speaker: Kevin J. Land, MD, CABP(AABB) – Vitalant
Speaker: J. Wade Atkins, MS, MLS, SBB, CQA, CABP(H) – NIH/CC/DTM
Biotherapies, Cellular Therapies, and Immunotherapies
Sunday, Oct 18th
9:45 AM - 11:00 AM EST
AM26-SU-30-L - AI-powered Accreditation Readiness: An Adoptable Model for Automated Quality Plan Gap Analysis
Room: GWCC B308/309
Program Chair: Wanxing Cui, MD, PhD, CABP(H) (he/him/his) – MedStar Georgetown University Hospital
Speaker: Joseph Schwartz, MD, MPH – Foundation for the Accreditation of Cellular Therapy (FACT)
Speaker: Jyotiska Biswas, n/a – ThinkTrends
Biotherapies, Cellular Therapies, and Immunotherapies
Sunday, Oct 18th
4:30 PM - 5:45 PM EST
AM26-SU-32-L - ABO-incompatible HSCT in Practice: Graft Processing Decisions, Titer Thresholds, and Transfusion Management
Room: GWCC B401-402
Program Chair: Wanxing Cui, MD, PhD, CABP(H) (he/him/his) – MedStar Georgetown University Hospital
Speaker: Eric A. Gehrie, MD – New York Blood Center Enterprises
Speaker: Stephanie Kinney, MD – Cincinnati Children's Hospital Medical Center
Speaker: Sachie Ikegami, MD, PhD, CABP – Hoxworth Blood Center/University of Cincinnati
Biotherapies, Cellular Therapies, and Immunotherapies
Monday, Oct 19th
8:15 AM - 9:15 AM EST
AM26-MO-03-L - Evidence-informed Donor Deferral Practices for Cellular Starting Material: Findings from a Multi-center Survey
Room: GWCC B313-314
Program Chair: Robert Marriott, n/a – Vitalant
Biotherapies, Cellular Therapies, and Immunotherapies
Monday, Oct 19th
2:00 PM - 3:00 PM EST
AM26-MO-20-L - Cosmetic Transfusion Medicine: Clinical Promise, Regulatory Gaps, and Quality Challenges
Room: GWCC B407
Program Chair: Robert A. DeSimone, MD – Weill Cornell Medicine
Speaker: Theresa N. Kinard, MD – Mayo Clinic College of Medicine and Science
Speaker: Jeffrey Lisiecki, MD – N/A
Biotherapies, Cellular Therapies, and Immunotherapies
Monday, Oct 19th
4:30 PM - 5:30 PM EST
AM26-MO-36-L - The Next Frontier: Advances in Car-t & Gene Therapy
Room: GWCC B405
Program Chair: Ronit Slotky, PhD, MSc, CABP (she/her/hers) – Hackensack University Medical Center
Speaker: David H. McKenna, MD – University of Minnesota Medical School
Speaker: Donald Siegel, PhD, MD (he/him/his) – University of Pennsylvania Perelman School of Medicine
Biotherapies, Cellular Therapies, and Immunotherapies